Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.59 -1.05 (-0.86%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.13 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Cowen Health Care Conference Transcript

Mar 07, 2023 / 05:50PM GMT
Release Date Price: $139.03 (-2.63%)
Unidentified Analyst

(technical difficulty) Kim and John, for joining us and making the long trip out. I know it's the 43rd annual -- Bruce, I can't remember when we first got together, but it's been a lot of years. All of a sudden, I was trying to count it up. Why don't we just start off? I know maybe you want to make some opening comments. And then we'll get into Q&A.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Yes, so happy to -- let me start out with the exciting opening comments. We're going to make forward-looking statements. See our risk factors. If I refer to non-GAAP financials, we always have a reconciliation on our website. I'll also point out if you're watching me in the room, I have a tremor in my right hand, that's not nerves. If my left hand starts shaking, I'm nervous. So you can differentiate on that.

I'm joined by 2 colleagues here in front of you. Kim Sablich has been with the company since June 1, 2020, runs our U.S. commercial business, overseen a number of successful launches already during her tenure.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot